Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale

John D. Fisk; Paul G. Ritvo; Lynn Ross; David A. Haase; Thomas J. Marrie; Walter F. Schlech

doi:10.1093/clinids/18.Supplement_1.S79

Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale

John D. Fisk, Paul G. Ritvo, Lynn Ross, David A. Haase, Thomas J. Marrie, Walter F. Schlech

Medicine

Résultat de recherche: Article › examen par les pairs

1252 Citations (Scopus)

Résumé

The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was >.87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patients' attribution of functional limitations to symptoms of fatigue.

Langue d'origine	English
Pages (de-à)	S79-S83
Journal	Clinical Infectious Diseases
Volume	18
DOI	https://doi.org/10.1093/clinids/18.Supplement_1.S79
Statut de publication	Published - janv. 1994

Note bibliographique

Funding Information:
Grant support: This research was supported by a grant from The National Health Research and Development Program (Health and Welfare Canada) and by a grant from Maritime Life Assurance Company.

ASJC Scopus Subject Areas

Microbiology (medical)
Infectious Diseases

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1093/clinids/18.Supplement_1.S79

Autres fichiers et liens

Citer

Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases, 18, S79-S83. https://doi.org/10.1093/clinids/18.Supplement_1.S79

@article{dda988e8c7074da5bb7b166ce455d520,

title = "Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale",

abstract = "The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was >.87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patients' attribution of functional limitations to symptoms of fatigue.",

author = "Fisk, {John D.} and Ritvo, {Paul G.} and Lynn Ross and Haase, {David A.} and Marrie, {Thomas J.} and Schlech, {Walter F.}",

note = "Funding Information: Grant support: This research was supported by a grant from The National Health Research and Development Program (Health and Welfare Canada) and by a grant from Maritime Life Assurance Company.",

year = "1994",

month = jan,

doi = "10.1093/clinids/18.Supplement_1.S79",

language = "English",

volume = "18",

pages = "S79--S83",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Measuring the functional impact of fatigue

T2 - Initial validation of the fatigue impact scale

AU - Fisk, John D.

AU - Ritvo, Paul G.

AU - Ross, Lynn

AU - Haase, David A.

AU - Marrie, Thomas J.

AU - Schlech, Walter F.

N1 - Funding Information: Grant support: This research was supported by a grant from The National Health Research and Development Program (Health and Welfare Canada) and by a grant from Maritime Life Assurance Company.

PY - 1994/1

Y1 - 1994/1

N2 - The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was >.87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patients' attribution of functional limitations to symptoms of fatigue.

AB - The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was >.87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patients' attribution of functional limitations to symptoms of fatigue.

UR - http://www.scopus.com/inward/record.url?scp=0027955307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027955307&partnerID=8YFLogxK

U2 - 10.1093/clinids/18.Supplement_1.S79

DO - 10.1093/clinids/18.Supplement_1.S79

M3 - Article

C2 - 8148458

AN - SCOPUS:0027955307

SN - 1058-4838

VL - 18

SP - S79-S83

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

ER -

Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale

Résumé

Note bibliographique

ASJC Scopus Subject Areas

ODD de l’ONU

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer